Plain-English translation of NCT05846581 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is tracking how well the GORE® ACUSEAL Vascular Graft works when used to create dialysis access in patients with end-stage kidney disease. Researchers want to gather real-world information about the safety and performance of this graft by following patients like you over 24 months after it's implanted.
End-stage kidney disease patients need reliable access to blood vessels for hemodialysis treatments. This registry exists to understand how well this new graft performs in everyday clinical practice and to make sure it's safe for long-term use.
You likely qualify if…
You likely don't qualify if…
After you receive the graft implant, you'll be followed for 24 months with check-ups at your dialysis center according to standard medical practice. Your doctors will monitor how well the graft is working, watch for any complications, and make sure you're healing properly. You'll continue your regular dialysis treatments while participating in the registry.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Germany
Italy
United Kingdom